Yıl: 2021 Cilt: 30 Sayı: 3 Sayfa Aralığı: 257 - 264 Metin Dili: İngilizce DOI: 10.37845/ret.vit.2021.30.45

Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study

Öz:
Purpose: To investigate optical coherence tomography angiography (OCTA) findings in patients with psoriasis. Materials and Methods: The study included 31 treatment-naive psoriasis patients without ocular involvement and 29 age- and sex- matched controls. Psoriasis was classified using the psoriasis area and severity index (PASI) score. Superficial and deep vascular densities (SVD, DVD), foveal avascular zone (FAZ) area, perimetry, foveal density (FD) 300μm around the FAZ, central macular thickness (CMT) and subfoveal choroidal thickness (SFCT) were measured with the Optovue OCTA device. The groups were compared statistically. Results: There was no difference between groups regarding age and gender (p:0,6 ve 0,2 respectively). Of the cases with psoriasis, 16% had arthritis and 45% had nail involvement. Median (min-max) disease duration was 10 years (1-48 years) and PASI score was 10 (2,20-42). The mean SVD and DVD were comparable between the groups (p:0,73 and 0,97 respectively). There was no significant difference in mean FAZ area, perimetry and FD between the patients and the controls. There was no correlation between the OCTA metrics and the severity, duration, nail and joint involvement of the disease (p>0,05 for all values). Additionally there was no significant difference between mild and severe psoriasis cases (p>0.05). Conclusion: OCTA is a promising technique for imaging the retinal microvascular system in psoriasis cases. However, it seems to have a limited role in detecting early subclinical changes in cases without ocular involvement. Key words: Foveal avascular zone, optical coherence tomography angiography, PASI score, psoriasis, vascular density.
Anahtar Kelime:

Konular:
Fen > Tıp > Göz Hastalıkları
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Bibliyografik
  • 1. Steiner M, Esteban-Ortega M del M, Muñoz-Fernández S. Choroidal and retinal thickness in systemic autoimmune and inflammatory diseases: A review. Surv Ophthalmol 2019; 64: 757-69.
  • 2. Rajguru JP, Maya D, Kumar D, et al. Update on psoriasis: A review. J Fam Med Prim Care 2020; 9: 20-4.
  • 3. Kalkan G. [Comorbidities in psoriasis: The recognition of psoriasis as a systemic disease and current management]. Turkderm-Turk Arch Dermatol Venereol 2017; 51: 71-7.
  • 4. Au S-C, Yaniv S, Gottlieb AB. Psoriatic Eye Manifestations. J Psoriasis Psoriatic Arthritis 2018; 17: 169-79.
  • 5. Yen YC, Weng SF, Lai FJ, et al. Risk of retinal vein occlusion in patients with psoriasis. Retina 2015; 35: 1786-94.
  • 6. Korkmaz S, Guclu H, Hatipoglu S, et al. Metabolic Syndrome May Exacerbate Macular and Retinal Damage in Psoriasis Vulgaris. Ocul Immunol Inflamm 2019; 27: 798-804.
  • 7. Chimenti MS, Triggianese P, Salandri G, et al. A Multimodal Eye Assessment in Psoriatic Arthritis Patients sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation. J Clin Med 2020; 9: 719.
  • 8. Deniz Demir H, Kalkan G, Kurt S, et al. Relationship between retinal sensitivity and disease activity in patients with psoriasis vulgaris. Clinics 2015; 70: 14-1.
  • 9. Campanati A, Neri P, Giuliodori K, et al. Psoriasis beyond the skin surface: a pilot study on the ocular involvement. Int Ophthalmol 2015; 35: 331-40.
  • 10. Doğan S, Atakan N, Koç Yıldırım S, et al. [Evaluation of psoriasis patients with a rheumatologic questionnaire efficiently aids in early detection of psoriatic arthritis]. Turkderm-Turk Arch Dermatol Venereol 2017; 51: 88-91.
  • 11. Turkcu FM, Sahin A, Yuksel H, et al. Evaluation of choroidal thickness in psoriasis using optical coherence tomography. Int Ophthalmol 2016; 36: 851-4.
  • 12. Ersan I, Kilic S, Arikan S, et al. Evaluation of Macular Ganglion Cell-inner Plexiform Layer and Choroid in Psoriasis Patients Using Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography. Ocul Immunol Inflamm 2017; 25: 520- 4.
  • 13. Kilic R, Kurt A, Acer E, et al. Choroidal thickness in psoriasis. Int Ophthalmol 2017; 37: 173-7.
  • 14. Spaide R, Fujimoto J, Waheed N, et al. Optical coherence tomography angiography. Prog Retin Eye Res 2017; 101: 985-8.
  • 15. Nakayama LF, Bergamo VC, Conti ML, et al. The retinal foveal avascular zone as a systemic biomarker to evaluate inflammatory bowel disease control. Int J Retin Vitr 2019; 5: 4-7.
  • 16. Çavdarli C, Çavdarli B, Topcu-Yilmaz P, et al. Optical coherence tomography-angiographic vascular densities in Familial Mediterranean Fever (FMF) Patients with M694V Mutations. Ophthalmic Genet 2020; 1-6.
  • 17. Goker YS, Yılmaz S, Kızıltoprak H, et al. Quantitative Analysis of Optical Coherence Tomography Angiography Features in Patients with Nonocular Behcet’s Disease. Curr Eye Res 2019; 44: 212-8.
  • 18. Morsy H, Kamp S, Thrane L, et al. Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity. Arch Dermatol Res 2010; 302: 105-11.
  • 19. Deegan AJ, Talebi-Liasi F, Song S, et al. Optical coherence tomography angiography of normal skin and inflammatory dermatologic conditions. Lasers Surg Med 2018; 50: 183-93.
  • 20. Schmitt J, Wozel G. The psoriasis area and severity index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005; 210: 194-9.
  • 21. Özyurt K, Ertaş R, Ertaş ŞK. [Treatment of Psoriatic Arthritis and Turkish Psoriasis Treatment Guideline-2016]. J Anatol Med Res 2018; 3: 62-7.
  • 22. Boehncke WH, Boehncke S, Tobin AM, et al. The ‘psoriatic march’: A concept of how severe psoriasis may drive cardiovascular comorbidity. Exp Dermatol 2011; 20: 303-7.
  • 23. Davidovici BB, Sattar N, Jörg PC, et al. Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions. J Invest Dermatol 2010; 130: 1785-96.
  • 24. Heidenreich R, Röcken M, Ghoreschi K. Angiogenesis drives psoriasis pathogenesis. Int J Exp Pathol 2009; 90: 232-48.
  • 25. Ghalamkarpour F, Baradaran-Rafii A, Sadoughi MM, et al. Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study. J Dermatolog Treat 2020; 31: 27-32.
  • 26. Demerdjieva Z, Mazhdrakova I, Tsankov N. Ocular changes in patients with psoriasis. Clin Dermatol 2019; 37: 663-7.
  • 27. Rehal B, Modjtahedi BS, Morse LS, et al. Ocular psoriasis. J Am Acad Dermatol 2011; 65: 1202-12.
  • 28. Shoeibi N, Taheri AR, Nikandish M, et al. Electrophysiologic evaluation of retinal function in patients with psoriasis and vitiligo. Doc Ophthalmol 2014; 128: 131-6.
  • 29. Perossini M, Turio E, Perossini T, et al. Pattern VEP alterations in psoriatic patients may indicate a subclinic optic neuritis. Doc Ophthalmol 2005; 110: 203-7.
  • 30. Grzybowski A, Grzybowski G, Druzdz A, et al. Visual evoked potentials in patients with psoriasis vulgaris. Doc Ophthalmol 2001; 103: 187-94.
  • 31. Koca S, Onan D, Kalaycı D, et al. Comparison of Optical Coherence Tomography Angiography Findings in Patients with Behçet’s Disease and Healthy Controls. Ocul Immunol Inflamm 2019; 0: 1-8.
  • 32. Akkurt ZM, Gümüş H, Aktürk A, et al. Evaluation of orbital arteries with colour Doppler ultrasonography in patients with psoriasis. Clin Exp Dermatol 2015; 40: 507-12.
  • 33. Ciccone M, Vettor R, Pannacciulli N, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes 2001; 25: 805-10.
  • 34. Chen YJ, Wu CY, Shen JL, et al. Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Arch Dermatol 2008; 144: 1571-5.
APA Altınışık M, BIÇAK F, MUTLU E, KURT E, MAYALI H, ERMERTCAN A (2021). Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study. Retina-Vitreus, 30(3), 257 - 264. 10.37845/ret.vit.2021.30.45
Chicago Altınışık Muhammed,BIÇAK Faruk,MUTLU Emine,KURT Emin,MAYALI Hüseyin,ERMERTCAN Aylin Turel Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study. Retina-Vitreus 30, no.3 (2021): 257 - 264. 10.37845/ret.vit.2021.30.45
MLA Altınışık Muhammed,BIÇAK Faruk,MUTLU Emine,KURT Emin,MAYALI Hüseyin,ERMERTCAN Aylin Turel Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study. Retina-Vitreus, vol.30, no.3, 2021, ss.257 - 264. 10.37845/ret.vit.2021.30.45
AMA Altınışık M,BIÇAK F,MUTLU E,KURT E,MAYALI H,ERMERTCAN A Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study. Retina-Vitreus. 2021; 30(3): 257 - 264. 10.37845/ret.vit.2021.30.45
Vancouver Altınışık M,BIÇAK F,MUTLU E,KURT E,MAYALI H,ERMERTCAN A Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study. Retina-Vitreus. 2021; 30(3): 257 - 264. 10.37845/ret.vit.2021.30.45
IEEE Altınışık M,BIÇAK F,MUTLU E,KURT E,MAYALI H,ERMERTCAN A "Retinal Vessel Density and Foveal Avascular Zone Analysis in Patients with Psoriasis: An Optical Coherence Tomography Angiography Study." Retina-Vitreus, 30, ss.257 - 264, 2021. 10.37845/ret.vit.2021.30.45